Advertisement
Advertisement
Pharmaxis Ltd (UUD.F)
Frankfurt - Frankfurt Delayed Price. Currency in EUR
Follow
At close: 09:15AM CET
Advertisement
Full screen
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Performance Outlook
| Previous Close | 0.0340 |
| Open | 0.0330 |
| Bid | 0.0330 x 5195200 |
| Ask | 0.0430 x 4188800 |
| Day's Range | 0.0330 - 0.0330 |
| 52 Week Range | 0.0310 - 0.0620 |
| Volume | |
| Avg. Volume | 671 |
| Market Cap | 27.25M |
| Beta (5Y Monthly) | 0.47 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.0200 |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A
Subscribe to Yahoo Finance Plus to view Fair Value for UUD.F
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
- Simply Wall St.
Pharmaxis Ltd (ASX:PXS) insider upped their holding by 71% earlier this year
From what we can see, insiders were net buyers in Pharmaxis Ltd's ( ASX:PXS ) during the past 12 months. That is...
- Simply Wall St.
Companies Like Pharmaxis (ASX:PXS) Are In A Position To Invest In Growth
Just because a business does not make any money, does not mean that the stock will go down. For example, biotech and...
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
© 2023 Yahoo. All rights reserved.
